Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
71 participants
OBSERVATIONAL
2020-01-01
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The data were collected retrospectively in each study site.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study design and settings: This is a retrospective comparison study in two NICUs: a Level IV in Japan and a Level III in Finland.
Patients: Eligible infants are those who were born between 28+0 and 31+6 weeks of gestation and who were discharged home from the study sites between January 2020 and December 2021. Infants will be excluded if (1) they have major anomalies at birth, (2) they are not discharged home from the study sites, or (3) they are discharged home with oxygen and/or after tracheostomy.
Outcome measures: The primary outcomes are the most common last discharge criterion between the two NICUs, and the potential shortening effects of each discharge criterion on the length of stay. The secondary outcome is the postmenstrual age (PMA) for each discharge criterion.
Statistics: The comparison between two continuous variables will be carried out by the student t test.
Ethics: The Ethics Committee of Nagano Children's Hospital gave ethical approval to this study. The study permission was obtained in both study sites.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Japan
Preterm infants born at 28 to 31 gestational weeks in 2020-2021 in a Level IV NICU in Japan
No interventions assigned to this group
Finland
Preterm infants born at 28 to 31 gestational weeks in 2020-2021 in a Level III NICU in Finland
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Discharged home from the study sites between January 2020 and December 2021
Exclusion Criteria
* Need for home oxygen therapy, tracheostomy, and/or gastrostomy at discharge
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nagano Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ryo Itoshima
Chief physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ryo Itoshima, MD
Role: PRINCIPAL_INVESTIGATOR
Nagano Children's Hospital
Liisa Lehtonen, MD
Role: STUDY_DIRECTOR
Turku University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nagano Children's Hospita
Azumino, Nagano, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-04-49
Identifier Type: -
Identifier Source: org_study_id